RT Journal Article
SR Electronic
T1 Trans-ethnic genome-wide meta-analysis of 35,732 cases and 34,424 controls identifies novel genomic cross-ancestry loci contributing to lung cancer susceptibility
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.06.20207753
DO 10.1101/2020.10.06.20207753
A1 Byun, Jinyoung
A1 Han, Younghun
A1 Li, Yafang
A1 Xia, Jun
A1 Xiao, Xiangjun
A1 Sun, Ryan
A1 Walsh, Kyle M.
A1 Gorlov, Ivan
A1 Gorlova, Olga
A1 Zhou, Wen
A1 Pettit, Rowland W
A1 Song, Zhuoyi
A1 Rosenberg, Susan M
A1 Zhu, Dakai
A1 Wiencke, John K.
A1 Albanes, Demetrius
A1 Lam, Stephan
A1 Tardon, Adonina
A1 Chen, Chu
A1 Goodman, Gary
A1 Bojeson, Stig
A1 Brenner, Hermann
A1 Landi, Maria Teresa
A1 Johansson, Mattias
A1 Mulley, Thomas
A1 Risch, Angela
A1 Wichmann, H-Erich
A1 Bickeböller, Heike
A1 Christiani, David C.
A1 Rennert, Gad
A1 Arnold, Susanne
A1 Field, John K.
A1 Shete, Sanjay
A1 LeMarchand, Loic
A1 Melander, Ole
A1 Brunnstrom, Hans
A1 Liu, Geoffrey
A1 Andrew, Angeline S.
A1 Kiemeney, Lambertius A.
A1 Shen, Hongbing
A1 Zienolddiny, Shan
A1 Grankvist, Kjell
A1 Johansson, Mikael
A1 Caporaso, Neil
A1 Cox, Angela
A1 Hong, Yun-Chul
A1 Yuan, Jian-Min
A1 Lazarus, Philip
A1 Schabath, Matthew B.
A1 Aldrich, Melinda C.
A1 Patel, Apla
A1 Lan, Qing
A1 Rothman, Nat
A1 Taylor, Fiona
A1 Spitz, Margaret
A1 Brennan, Paul
A1 Lin, Xihong
A1 McKay, James
A1 Hung, Rayjean J.
A1 Amos, Christopher I.
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/10/07/2020.10.06.20207753.abstract
AB Lung cancer is the leading cause of cancer death worldwide. Genome-wide association studies have revealed genetic risk factors, highlighting the role of smoking, family history, telomere regulation, and DNA damage-repair in lung cancer etiology. Many studies have focused on a single ethnic group to avoid confounding from variability in allele frequencies across populations; however, comprehensive multi-ethnic analyses may identify variants that are more likely to be causal. This large-scale, multi- ethnic meta-analyses identified 28 novel risk loci achieving genome-wide significance. Leading candidates were further studied using single-cell methods for evaluating DNA-damage. DNA-damage promoting activities were confirmed for selected genes by knockdown genes and overexpression studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur study was supported by the National Institutes of Health (NIH) for Integrative Analysis of Lung Cancer Etiology and Risk (U19CA203654) and Cancer Prevention Research Interest of Texas (CPRIT) award (RR170048). Functional Studies for this research was partially supported by NIH grants (R01CA250905 and DP1-AG072751). The Resource for the Study of Lung Cancer Epidemiology in North Trent (ReSoLuCENT) study was funded by the Sheffield Hospitals Charity, Sheffield Experimental Cancer Medicine Centre and Weston Park Hospital Cancer Charity. FT was supported by a clinical PhD fellowship funded by the Yorkshire Cancer Research/Cancer Research UK Sheffield Cancer Centre.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available at the database of Genotypes and Phenotypes (dbGaP). The access numbers are phs001273.v3.p2 for OncoArray study, phs000876.v2.p1 for Affymetrix study, phs000716.v1.p1 for FLCCA study, phs001210.v1.p1 for NCI study, and phs000629.v1.p1 for GELCC study. Other data that support the findings of this study are available from the corresponding author upon request and are also reported as summary data in phs001273.v3.p2